Eravacycline
CHEBI:CHEBI_177804
Chemical Information
- Molecular Formula
- C27H31FN4O8
- Molecular Mass
- 558.563
- Charge
- 0
- SMILES
- FC1=C2C[C@]3(C[C@@]4([C@](O)(C(=O)C3=C(O)C2=C(O)C(NC(=O)CN5CCCC5)=C1)C(O)=C(C(=O)[C@H]4N(C)C)C(=O)N)[H])[H]
- InChI
- InChI=1S/C27H31FN4O8/c1-31(2)20-13-8-11-7-12-14(28)9-15(30-16(33)10-32-5-3-4-6-32)21(34)18(12)22(35)17(11)24(37)27(13,40)25(38)19(23(20)36)26(29)39/h9,11,13,20,34-35,38,40H,3-8,10H2,1-2H3,(H2,29,39)(H,30,33)/t11-,13-,20-,27-/m0/s1
- InChIKey
- AKLMFDDQCHURPW-ISIOAQNYSA-N
Alternative Names
- (4S,4aS,5aR,12aR)-4-(dimethylamino)-7-luoro-1,10,11,12a-tetrahydroxy-3,12-dioxo-9-[(2-pyrrolidin-1-ylacetyl)amino]-4a,5,5a,6-tetrahydro-4H-tetracene-2-carboxamide
Drug Classification
-
processed material
-
tetracyclinesView Class →
CHEBI:26895
Important Medical Information
⚕️ This information is sourced from ChEBI (Chemical Entities of Biological Interest) database and is intended for educational purposes only.
- Always consult with a healthcare professional before starting, stopping, or modifying any medication.
- Side effects may vary and this list may not be comprehensive.
- Drug interactions may occur with other medications.
Additional Identifiers
- DRON_00010000
- 2055906
- core#notation
- CHEBI:177804
- oboInOwl#hasDbXref
- PDBeChem:YQM
Additional References
🔍 Click on any linked disease name to learn more about the conditions this medication is used to treat, or explore related drug classifications for more information about similar medications.
Additional Attributes
- oboInOwl#hasOBONamespace
- chebi_ontology
- DRON_00010000
- 2055906
- oboInOwl#id
- CHEBI:177804
- core#notation
- CHEBI:177804
- oboInOwl#hasDbXref
- PDBeChem:YQM
- generic_name
- eravacycline
- rxcui
- 2374558
- product_type
- HUMAN PRESCRIPTION DRUG
- marketing_category
- NDA
- listing_expiration_date
- 20251231
- active_ingredient_strength
- 50 mg/1
- pharm_class
- Tetracycline-class Antibacterial [EPC]
- route
- INTRAVENOUS
- dosage_form
- INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
- marketing_start_date
- 20180910
- package_marketing_start_date
- 20200914
- brand_name
- Xerava
- brand_name_base
- Xerava
- product_ndc
- 71773-050
- application_number
- NDA211109
- labeler_name
- Tetraphase Pharmaceuticals, Inc.
- manufacturer_name
- Tetraphase Pharmaceuticals, Inc.
- spl_id
- f025d360-5b88-4bb3-8d42-0ae12fa375a8
- active_ingredient_name
- ERAVACYCLINE DIHYDROCHLORIDE
- package_ndc
- 71773-050-12
- package_description
- 12 VIAL, GLASS in 1 CARTON (71773-050-12) / 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL, GLASS
- unii
- WK1NMH89VJ
- spl_set_id
- a4b188d4-f467-470c-ad7b-25ffbdd8862a
- upc
- 0371773100052
- oboInOwl#inSubset
- http://purl.obolibrary.org/obo/chebi#2_STAR
- 22-rdf-syntax-ns#type
- http://www.w3.org/2002/07/owl#Class
- has_treatment
- http://purl.obolibrary.org/obo/DOID_10957
- owl#annotatedSource
- t137125
- owl#someValuesFrom
- t3318508